SCHEDULE 13G 0002116521 XXXXXXXX LIVE Common Stock, $0.0001 par value per share 03/06/2026 0001930313 SBC Medical Group Holdings Inc 73245B107 200 Spectrum Center Dr. STE 300 Irvine CA 92618 Rule 13d-1(c) Aikawa Equity Management Co., Ltd. M0 5284500.00 0.00 5284500.00 0.00 5284500.00 N 5.2 OO Row 11 is based on 102,576,943 shares of Common Stock, $0.0001 par value per share ("Common Stock") of SBC Medical Group Holdings Incorporated (the "Issuer") outstanding on December 26, 2025 as disclosed in the Issuer's prospectus filed with the SEC on January 5, 2026. SBC Medical Group Holdings Inc 200 Spectrum Center Dr. STE 300 Irvine, CA, 92618 Aikawa Equity Management Co., Ltd 908 Kamikurata-Cho, Totsuka-ku, Yokohama, Kanagawa, 244-0816 Japan Y The information relating to the beneficial ownership of the Common Stock by the Reporting Person set forth in Rows 5 through 11 of the cover page hereto and related footnote are incorporated by reference herein. The Reporting Person acquired the Common Stock disclosed on this Schedule 13G pursuant to a subscription agreement dated December 23, 2025, between Dr. Yoshiyuki Aikawa, Chief Executive Officer of the Issuer, and the Reporting Person. As of March 6, 2026, Dr. Aikawa ceased to have voting and dispositive power over the Common Stock held by the Reporting Person. 5.2% 5,284,500 0 5,284,500 0 Y N Commencing on March 6, 2026, Dr. Aikawa entered into agreements with certain consultants providing services to medical corporations that have entered into contractual and service arrangements with subsidiaries of the Issuer pursuant to which such consultants acquired equity interests in the Reporting Person and the right to redeem those interests in exchange for proceeds from the sale of Common Stock held by the Reporting Person, subject to the terms of the such interests. Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Aikawa Equity Management Co., Ltd. /s/ Daisuke Nakamura 03/13/2026